Karen Weintraub is a freelance writer based in Boston, Massachusetts.
Karen Weintraub
Freelance Writer
Simons Foundation/Freelance
From this contributor
Technique follows calcium trail to track changes in signaling
Researchers have genetically engineered neurons to fluoresce in response to the calcium signals emitted when they fire, according to a study published 18 October in Neuron.
Technique follows calcium trail to track changes in signaling
Researchers uncover new drug target for fragile X
Deleting an enzyme that regulates protein synthesis reverses some of the molecular and behavioral deficits in a mouse model of fragile X syndrome, according to research published 2 October in Neuron.
Researchers uncover new drug target for fragile X
Drug improves social deficits in fragile X syndrome
A drug called arbaclofen improves behavioral problems in people with fragile X syndrome, an inherited condition that can lead to mental retardation and autism, according to the results of a clinical trial published today in Science Translational Medicine. A second study published in the same journal showed that the drug restores normal brain function in a mouse model of the disorder.
Drug improves social deficits in fragile X syndrome
Explore more from The Transmitter
A brief history of precision self-scanning
When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.
A brief history of precision self-scanning
When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.
Sensory profiles in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 January.
Sensory profiles in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 January.
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.